SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-066026
Filing Date
2015-11-16
Accepted
2015-11-16 16:17:47
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v424731_10q.htm 10-Q 278272
2 EXHIBIT 10.1 v424731_ex10-1.htm EX-10.1 69459
3 EXHIBIT 31.1 v424731_ex31-1.htm EX-31.1 9062
4 EXHIBIT 31.2 v424731_ex31-2.htm EX-31.2 9783
5 EXHIBIT 32.1 v424731_ex32-1.htm EX-32.1 4792
6 EXHIBIT 32.2 v424731_ex32-2.htm EX-32.2 4659
  Complete submission text file 0001144204-15-066026.txt   1880229

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT accp-20150930.xml EX-101.INS 225220
8 XBRL TAXONOMY EXTENSION SCHEMA accp-20150930.xsd EX-101.SCH 18730
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE accp-20150930_cal.xml EX-101.CAL 52187
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE accp-20150930_def.xml EX-101.DEF 59372
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE accp-20150930_lab.xml EX-101.LAB 279848
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE accp-20150930_pre.xml EX-101.PRE 154159
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 151234726
SIC: 2834 Pharmaceutical Preparations